CanSino Biologics
| CanSino Biologics | |
|---|---|
| Тип | Публичная компания |
| Листинг на бирже | SEHK: 6185 |
| Дата основания | 2009 |
| Основатели | Юй Сюэфэн; Чжу Тао; Цю Дунсю; Хелен Мао Хуэйхуа |
| Расположение | Тяньцзинь, Китай |
| Отрасль | Фармацевтическая промышленность |
| Сайт | cansinotech.com (англ.); cansinotech.com.cn |
CanSino Biologics (), нередко применяется сокращённое название CanSinoBIO — китайская биофармацевтическая компания, занимающаяся исследованием, разработкой и производством вакцин. Разработчик Вакцины против COVID-19 Ad5-nCoV, основанной на нереплицирующемся Аденовирусном векторе серотипа 5.
История
Компания CanSino Biologics была основана в 2009 году в Тяньцзине Юй Сюэфэном, Чжу Тао, Цю Дунсю и Хелен Мао Хуэйхуа.
В июле 2018 года компания подала заявку на листинг на Гонконгской фондовой бирже. 28 марта 2019 года состоялся выход компании на Гонконгскую фондовую биржу с ростом на 59 %, став самым высоким показателем первого дня торгов в Гонконге с 2017 года.
В августе 2020 года компания завершила вторичное размещение акций на, где привлекла 5,2 млрд юаней (750 млн долларов США).
Вакцины
У компании есть портфель исследуемых вакцин, включая Ad5-EBOV для предотвращения лихорадки Эбола и Ad5-nCoV для COVID-19. Компания ранее сотрудничала с Национальным научно-исследовательским советом Канады (NRC) в разработке вакцины. Эти две организации начали сотрудничать в 2013 году, а впоследствии они работали вместе над разработкой вакцины против Эболы.
Разработка вакцины против COVID-19
AD5-nCOV, торговое название Convidecia, представляет собой однократную вирусную векторную вакцину против COVID-19, разработанную компанией CanSino. С конца 2020 года препарат проходит III фазу испытаний в Чили, Мексике, Пакистане, России и Саудовской Аравии с 40 000 участников.
В феврале 2021 года глобальные данные испытаний фазы III и 101 случай COVID показали, что эффективность вакцины в предотвращении умеренных симптомов COVID-19 составила 65,7%, а в предотвращении тяжелого заболевания – 91%. По эффективности она аналогична вакцине Johnson & Johnson, еще одной одноразовой векторной вакцине против аденовируса с эффективностью 66% в глобальных испытаниях. Режим однократной дозы и нормальные требования к хранению в холодильнике делают эту вакцину подходящей для многих стран. В настоящее время ВОЗ проводит оценку для включения в список использования в чрезвычайных ситуациях.
Convidecia одобрена для использования в некоторых странах Азии, Европы, и Латинской Америки. В 2021 году производственные мощности Ad5-NCov должны достичь 500 миллионов доз. Производство будет осуществляться в Китае, Малайзии, Мексике и Пакистане.
Инвесторы
По состоянию на 2018 год среди инвесторов CanSino Biologics были Lilly Asia Ventures, Qiming Venture Partners и SDIC Fund Management.
Примечания
- Eric Ng: "Chinese vaccine maker CanSino faces tough IPO sell in wake of Changsheng Bio-technology scandal" — https://www.scmp.com/business/article/2156867/chinese-vaccine-maker-cansino-faces-tough-ipo-sell-wake-changsheng-bio
- https://www.scmp.com/business/article/2156867/chinese-vaccine-maker-cansino-faces-tough-ipo-sell-wake-changsheng-bio
- https://web.archive.org/web/20200105050906/https://www.scmp.com/business/article/2156867/chinese-vaccine-maker-cansino-faces-tough-ipo-sell-wake-changsheng-bio
- Low: Ebola vaccine maker CanSino Biologics has a plan to take its life-saving treatments well beyond China's domestic market — https://www.scmp.com/business/companies/article/3003886/ebola-vaccine-maker-cansino-biologics-has-plan-take-its-life
- https://www.scmp.com/business/companies/article/3003886/ebola-vaccine-maker-cansino-biologics-has-plan-take-its-life
- https://web.archive.org/web/20191015091517/https://www.scmp.com/business/companies/article/3003886/ebola-vaccine-maker-cansino-biologics-has-plan-take-its-life
- Daniel Ren: "Covid-19 vaccine maker CanSino soars in Star Market debut" — https://www.scmp.com/business/companies/article/3097165/cansino-biologics-chinas-first-drug-maker-start-human-trials
- https://www.scmp.com/business/companies/article/3097165/cansino-biologics-chinas-first-drug-maker-start-human-trials
- https://web.archive.org/web/20201116175501/https://www.scmp.com/business/companies/article/3097165/cansino-biologics-chinas-first-drug-maker-start-human-trials
- Zhuang Pinghui: "Volunteers needed for second phase of China coronavirus vaccine trial" — https://www.scmp.com/news/china/society/article/3079429/volunteers-needed-second-phase-china-coronavirus-vaccine-trial
- https://www.scmp.com/news/china/society/article/3079429/volunteers-needed-second-phase-china-coronavirus-vaccine-trial
- https://web.archive.org/web/20200427150720/https://www.scmp.com/news/china/society/article/3079429/volunteers-needed-second-phase-china-coronavirus-vaccine-trial
- Dr. Xuefeng Yu: "The National Research Council of Canada and CanSino Biologics Inc. announce collaboration to advance vaccine against COVID-19" — https://www.newswire.ca/news-releases/the-national-research-council-of-canada-and-cansino-biologics-inc-announce-collaboration-to-advance-vaccine-against-covid-19-816213726.html
- https://www.newswire.ca/news-releases/the-national-research-council-of-canada-and-cansino-biologics-inc-announce-collaboration-to-advance-vaccine-against-covid-19-816213726.html
- https://web.archive.org/web/20211107102300/https://www.newswire.ca/news-releases/the-national-research-council-of-canada-and-cansino-biologics-inc-announce-collaboration-to-advance-vaccine-against-covid-19-816213726.html
- "National Research Council contribution plays key role in newly approved Ebola vaccine" — https://www.newswire.ca/news-releases/national-research-council-contribution-plays-key-role-in-newly-approved-ebola-vaccine-677391803.html
- https://www.newswire.ca/news-releases/national-research-council-contribution-plays-key-role-in-newly-approved-ebola-vaccine-677391803.html
- https://web.archive.org/web/20211107104026/https://www.newswire.ca/news-releases/national-research-council-contribution-plays-key-role-in-newly-approved-ebola-vaccine-677391803.html
- Tom Blackwell: "Canada's surprising history and questionable partnership with a Chinese company and its military-backed COVID-19 vaccine" — https://nationalpost.com/health/canadas-surprising-history-and-questionable-partnership-with-a-chinese-company-and-its-military-backed-covid-19-vaccine
- https://nationalpost.com/health/canadas-surprising-history-and-questionable-partnership-with-a-chinese-company-and-its-military-backed-covid-19-vaccine
- Grady McGregor: "It's not just Johnson & Johnson: China has a single-dose COVID-19 vaccine that's 65% effective" — https://fortune.com/2021/02/09/china-covid-vaccine-single-dose-cansino-johnson-johnson/
- https://fortune.com/2021/02/09/china-covid-vaccine-single-dose-cansino-johnson-johnson/
- https://web.archive.org/web/20210808130747/https://fortune.com/2021/02/09/china-covid-vaccine-single-dose-cansino-johnson-johnson/
- "Gob.cl - Article: Science Minister: "We Work With Maximum Rigor So That Science And Technology Benefit People'S Health"" — https://www.gob.cl/en/news/science-minister-we-work-with-maximum-rigor-so-that-science-and-technology-benefit-peoples-health/
- https://www.gob.cl/en/news/science-minister-we-work-with-maximum-rigor-so-that-science-and-technology-benefit-peoples-health/
- https://web.archive.org/web/20201213233446/https://www.gob.cl/en/news/science-minister-we-work-with-maximum-rigor-so-that-science-and-technology-benefit-peoples-health/
- "Chinese Covid vaccine trials to be expanded to five more states" — https://mexiconewsdaily.com/news/chinese-covid-vaccine-trials-to-be-expanded-to-five-more-states/
- https://mexiconewsdaily.com/news/chinese-covid-vaccine-trials-to-be-expanded-to-five-more-states/
- https://web.archive.org/web/20210203091608/https://mexiconewsdaily.com/news/chinese-covid-vaccine-trials-to-be-expanded-to-five-more-states/
- "Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above - Full Text View - ClinicalTrials.gov" — https://clinicaltrials.gov/ct2/show/NCT04526990
- https://clinicaltrials.gov/ct2/show/NCT04526990
- https://web.archive.org/web/20200918142722/https://clinicaltrials.gov/ct2/show/NCT04526990
- Tom Balmforth: "Russia approves clinical trials for Chinese COVID-19 vaccine Ad5-Ncov: Ifax" — https://www.reuters.com/article/us-health-coronavirus-china-russia-idUSKBN28H0RN?edition-redirect=ca
- https://www.reuters.com/article/us-health-coronavirus-china-russia-idUSKBN28H0RN?edition-redirect=ca
- https://web.archive.org/web/20211107103735/https://www.reuters.com/article/us-health-coronavirus-china-russia-idUSKBN28H0RN?edition-redirect=ca
- Gibran Naiyyar Peshimam, Umar Farooq: "CanSinoBIO's COVID-19 vaccine 65.7% effective in global trials, Pakistan official says" — https://www.reuters.com/article/us-health-coronavirus-vaccine-pakistan/cansinobios-covid-19-vaccine-657-effective-in-global-trials-pakistan-official-says-idUSKBN2A81N0
- https://www.reuters.com/article/us-health-coronavirus-vaccine-pakistan/cansinobios-covid-19-vaccine-657-effective-in-global-trials-pakistan-official-says-idUSKBN2A81N0
- https://web.archive.org/web/20210324225256/https://www.reuters.com/article/us-health-coronavirus-vaccine-pakistan/cansinobios-covid-19-vaccine-657-effective-in-global-trials-pakistan-official-says-idUSKBN2A81N0
- Faseeh Mangi, Dong Lyu, Ismail Dilawar: "China's CanSino Covid Vaccine Shows 65.7% Efficacy" — https://www.bloomberg.com/news/articles/2021-02-08/pakistan-says-cansino-s-covid-vaccine-shows-65-7-efficacy
- https://www.bloomberg.com/news/articles/2021-02-08/pakistan-says-cansino-s-covid-vaccine-shows-65-7-efficacy
- https://web.archive.org/web/20210822122429/https://www.bloomberg.com/news/articles/2021-02-08/pakistan-says-cansino-s-covid-vaccine-shows-65-7-efficacy
- "Status of COVID-19 Vaccines within WHO EUL/PQ evaluation process" (PDF) — https://extranet.who.int/pqweb/sites/default/files/documents/Status_COVID_VAX_15July2021.pdf
- https://extranet.who.int/pqweb/sites/default/files/documents/Status_COVID_VAX_15July2021.pdf
- https://web.archive.org/web/20211001175555/https://extranet.who.int/pqweb/sites/default/files/documents/Status_COVID_VAX_15July2021.pdf
- Roxanne Liu: "China approves two more domestic COVID-19 vaccines for public use" — https://www.reuters.com/article/us-health-coronavirus-china-vaccine-idUSKBN2AP1MW
- https://www.reuters.com/article/us-health-coronavirus-china-vaccine-idUSKBN2AP1MW
- https://web.archive.org/web/20210503143326/https://www.reuters.com/article/us-health-coronavirus-china-vaccine-idUSKBN2AP1MW
- Jahangir Khan: "Pakistan purchases over 30 million COVID doses from China: sources" — https://arynews.tv/covid-vaccine-doses-pakistan-china-2/
- https://arynews.tv/covid-vaccine-doses-pakistan-china-2/
- https://web.archive.org/web/20211107123011/https://arynews.tv/covid-vaccine-doses-pakistan-china-2/
- "Malaysia to receive CanSino vaccine this month. The Malaysian Insight" — https://www.themalaysianinsight.com/s/308349
- https://www.themalaysianinsight.com/s/308349
- https://web.archive.org/web/20210514171531/https://www.themalaysianinsight.com/s/308349
- Rashmi Ashok: "UPDATE 2-China's CanSino Biologics COVID-19 vaccine receives emergency use approval in Hungary" — https://www.reuters.com/world/china/chinas-cansino-biologics-covid-19-vaccine-receives-emergency-use-approval-2021-03-22/
- https://www.reuters.com/world/china/chinas-cansino-biologics-covid-19-vaccine-receives-emergency-use-approval-2021-03-22/
- https://web.archive.org/web/20211107121709/https://www.reuters.com/world/china/chinas-cansino-biologics-covid-19-vaccine-receives-emergency-use-approval-2021-03-22/
- "Membrii NITAG au venit cu recomandări privind utilizarea vaccinurilor împotriva COVID-19 în Republica Moldova" — https://msmps.gov.md/comunicare/comunicate/membrii-nitag-au-venit-cu-recomandari-privind-utilizarea-vaccinurilor-impotriva-covid-19-in-republica-moldova/
- https://msmps.gov.md/comunicare/comunicate/membrii-nitag-au-venit-cu-recomandari-privind-utilizarea-vaccinurilor-impotriva-covid-19-in-republica-moldova/
- https://web.archive.org/web/20210519224416/https://msmps.gov.md/comunicare/comunicate/membrii-nitag-au-venit-cu-recomandari-privind-utilizarea-vaccinurilor-impotriva-covid-19-in-republica-moldova/
- Raul Cortes: "'Our gratitude always': From China's CanSino, Mexico welcomes biggest vaccine shipment yet" — https://www.reuters.com/business/healthcare-pharmaceuticals/our-gratitude-always-chinas-cansino-mexico-welcomes-biggest-vaccine-shipment-yet-2021-02-11/
- https://www.reuters.com/business/healthcare-pharmaceuticals/our-gratitude-always-chinas-cansino-mexico-welcomes-biggest-vaccine-shipment-yet-2021-02-11/
- https://web.archive.org/web/20211107122345/https://www.reuters.com/business/healthcare-pharmaceuticals/our-gratitude-always-chinas-cansino-mexico-welcomes-biggest-vaccine-shipment-yet-2021-02-11/
- Maximillian Heath: "Argentina issues emergency approval to China's single-dose Cansino COVID-19 vaccine" — https://www.reuters.com/world/americas/argentina-issues-emergency-approval-chinas-single-dose-cansino-covid-19-vaccine-2021-06-11/
- https://www.reuters.com/world/americas/argentina-issues-emergency-approval-chinas-single-dose-cansino-covid-19-vaccine-2021-06-11/
- https://web.archive.org/web/20210712093058/https://www.reuters.com/world/americas/argentina-issues-emergency-approval-chinas-single-dose-cansino-covid-19-vaccine-2021-06-11/
- Roxanne Liu and Ryan Woo: "China can hit 500-mln-dose annual capacity of CanSinoBIO COVID-19 vaccine this year" — https://finance.yahoo.com/news/china-hit-500-mln-dose-103509138.html
- https://finance.yahoo.com/news/china-hit-500-mln-dose-103509138.html
- https://web.archive.org/web/20210709190959/https://finance.yahoo.com/news/china-hit-500-mln-dose-103509138.html
- Daina Beth Solomon: "China's CanSino says first vaccines packaged in Mexico will be ready in March" — https://www.reuters.com/article/us-health-coronavirus-mexico-vaccine-idUSKCN2AS0P0
- https://www.reuters.com/article/us-health-coronavirus-mexico-vaccine-idUSKCN2AS0P0
- https://web.archive.org/web/20210515183952/https://www.reuters.com/article/us-health-coronavirus-mexico-vaccine-idUSKCN2AS0P0
- "Pakistan develops homemade anti-Covid vaccine 'PakVac'" — https://tribune.com.pk/story/2301333/pakistan-develops-homemade-anti-covid-vaccine-pakvac
- https://tribune.com.pk/story/2301333/pakistan-develops-homemade-anti-covid-vaccine-pakvac
- https://web.archive.org/web/20211107124344/https://tribune.com.pk/story/2301333/pakistan-develops-homemade-anti-covid-vaccine-pakvac
Ссылки
- Официальный сайт — http://www.cansinotech.com
- http://www.cansinotech.com